Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Baxter International Inc.    BAX   US0718131099

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Baxter International Inc.
Produces and supplies specialized medical products including biopharmaceuticals and medical equipment

Baxter International, Inc. through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.

Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.

It operates business through two segments: BioScience and Medical Products.

The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and select vaccines.

The Medical Products segment manufactures intravenous IV solutions and administration sets, premixed drugs and drug-reconstitution systems, prefilled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics.

The business also provides products and services related to pharmacy compounding, drug formulation and packaging technologies.

In addition, the Medical Products business provides products and services to treat end-stage renal disease, or irreversible kidney failure.

It also manufactures solutions and other products for peritoneal dialysis, a home-based therapy, and also distributes products for hemodialysis, which is generally conducted in a hospital or clinic.

Baxter International was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.
Sales per Businesses
20122013Delta
USD (in Million)%USD (in Million)%
Medical Products7,95356%8,69557% +8.53%
BioScience6,23743.9%6,56443% +4.98%
Other-----
Sales per Regions
20122013Delta
USD (in Million)%USD (in Million)%
United States6,05642.7%6,45142.3% +6.12%
Europe4,19629.6%4,59730.1% +8.72%
Asia-Pacific2,22915.7%2,37815.6% +6.27%
Latin America and Canada1,70912%1,83312% +6.76%
Managers
NameTitle
Robert L. ParkinsonChairman and Chief Executive Officer
David P. ScharfGeneral Secretary
Robert J. HombachChief Financial Officer
Surperformance© rating of Baxter International Inc.
Overall rating In sector In country
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector
Healthcare
Healthcare Services
 Healthcare Equipment / Supplies
  Medical Equipment / Supplies / Distribution
Shareholders
- BlackRock 6,40%
Advertisement
Sector Medical Equipment / Supplies / Distribution
Trading RatingInvestor Rating
BAXTER INTERNATIO..
COVIDIEN PLC
STRYKER CORPORATI..
BECTON, DICKINSON..
ESSILOR INTL.
Sector Medical Equipment / Supplies / Distribution
Company contact information
1 Baxter Parkway
US-IL 60015 Deerfield, Illinois
USA

Phone : +1 224 948 2000
Fax : +1
Internet : http://www.baxter.com
Markets and indexes
- NYSE Euronext
- Main Market
- SP100 / SP500
Stock Exchange Codes
- ISIN Code :  US0718131099
- Bloomberg Code :  BAX:US
- Reuters Code :  BAX.N
- Datastream Code :  
© 2014 Factset    © 2014 Cofisem   
Dynamic quotes  
ON
| OFF